Rchr
J-GLOBAL ID:201801018946450850   Update date: May. 18, 2024

Asada Kiyoshi

Asada Kiyoshi
Affiliation and department:
Research field  (2): Molecular biology ,  Internal medicine - General
Research keywords  (4): regulatory science ,  Gastroenterology ,  Liver fibrosis ,  Epigenetics
Research theme for competitive and other funds  (4):
  • 2021 - 2024 腎臓病進展予防を目指した治療介入アプリの開発
  • 2013 - 2016 Distribution of gastric epithelial cells with DNA methylation by Helicobacter pylori
  • 2005 - 2009 Identification of tumor suppressor genes in gastric cancers by genome-wide analysis of DNA methylation and its functional analysis
  • 1999 - 1999 Abnormalities in maintenance of methylation and carcinogenesis.
Papers (65):
  • Junya Suzuki, Tadashi Namisaki, Hiroaki Takya, Kosuke Kaji, Norihisa Nishimura, Akihiko Shibamoto, Shohei Asada, Takahiro Kubo, Satoshi Iwai, Fumimasa Tomooka, et al. ADAMTS-13: A Prognostic Biomarker for Portal Vein Thrombosis in Japanese Patients with Liver Cirrhosis. International Journal of Molecular Sciences. 2024. 25. 5. 2678-2678
  • Naoki Kawahara, Ryuji Kawaguchi, Konosuke Yamamoto, Kyohei Nishikawa, Motoki Matsuoka, Tomoka Maehana, Yosuke Fukui, Shoichiro Yamanaka, Sumire Sugimoto, Kana Iwai, et al. The clinical trial of alternative relugolix administration for uterine leiomyoma prior to surgically treatment: a study protocol for Non-Adverse Relugolix Administration (NARA) trial. Trials. 2024. 25. 1. 68-68
  • Tomoo Mano, Kiyoshi Asada, Shota Suzuki, Shu Kasama, Kaoru Kinugawa, Kazuma Sugie, Masato Kasahara, Akira Kido. Feasibility and acceptability of novel functional electronic stimulated rehabilitation application for treatment in patients with cerebrovascular disorders: the FRAT study protocol. Pilot and Feasibility Studies. 2022. 8. 1
  • Kei Moriya, Kiyoshi Asada, Shota Suzuki, Masahide Enomoto, Yukihisa Fujinaga, Yuki Tsuji, Tadashi Namisaki, Hitoshi Yoshiji. Benefit of glucosyl Hesperidin in patients with primary biliary cholangitis: A multicenter, open-label, randomized control study. Medicine. 2022. 101. 48. e32127-e32127
  • Tadashi Namisaki, Kosuke Kaji, Naotaka Shimozato, Daisuke Kaya, Takahiro Ozutsumi, Yuki Tsuji, Yukihisa Fujinaga, Koh Kitagawa, Masanori Furukawa, Shinya Sato, et al. Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology. 2022. 41. 2. 169-180
more...
MISC (22):
  • Yukihisa Fujinaga, Tadashi Namisaki, Kei Moriya, Mitsuteru Kitade, Hideto Kawaratani, Kosuke Kaji, Kenichiro Seki, Hiroaki Takaya, Yasuhiko Sawada, Takemi Akahane, et al. Possible Risk Factors for Histological Progression with Sequential Liver Biopsies in Primary Biliary Cholangitis Patients. HEPATOLOGY. 2018. 68. 1108A-1108A
  • Tadashi Namisaki, Yasushi Okura, Kosuke Kaji, Mitsuteru Kitade, Naotaka Shimozato, Kei Moriya, Shinya Sato, Hideto Kawaratani, Hiroaki Takaya, Yasuhiko Sawada, et al. Identification of Risk Factors for Histological Progression in Patients with Primary Biliary Cholangitis. HEPATOLOGY. 2018. 68. 1017A-1018A
  • Hiroaki Takaya, Tadashi Namisaki, Kosuke Kaji, Mitsuteru Kitade, Yuki Tsuji, Yukihisa Fujinaga, Masanori Furukawa, Keisuke Nakanishi, Kenichiro Seki, Shinya Sato, et al. Identification of Von Willebrand Factor-to-ADAMTS13 Ratio As a Potential Biomarker for Early Detection of Hepatocellular Carcinoma in Patients with Liver Cirrhosis. HEPATOLOGY. 2018. 68. 835A-835A
  • 大倉 康志, 浪崎 正, 守屋 圭, 北出 光輝, 竹田 幸祐, 瓦谷 英人, 鍛治 孝祐, 西村 典久, 澤田 保彦, 佐藤 慎哉, et al. アンギオテンシンII受容体拮抗薬およびDPP4阻害薬併用によるNASH肝病態進展抑制効果と作用機序. 日本消化器病学会雑誌. 2017. 114. 臨増総会. A308-A308
  • 西村 典久, 北出 光輝, 浪崎 正, 守屋 圭, 竹田 幸祐, 瓦谷 英人, 大倉 康志, 鍛治 孝祐, 高谷 広章, 佐藤 慎哉, et al. 非環式レチノイドとアンギオテンシンII受容体拮抗薬併用による肝発癌抑制効果とメカニズム. 日本消化器病学会雑誌. 2017. 114. 臨増総会. A319-A319
more...
Work history (7):
  • 2024/04 - 現在 Nara Medical University Institute for Clinical and Translational Science Associate Professor
  • 2021/04 - 2024/03 Nara Medical University Institute for Clinical and Translational Science Lecturer
  • 2019/04 - 2021/03 Pharmaceuticals and Medical Devices Agency (PMDA) Office of New Drug I Reviewer
  • 1996 - 2019/03 Nara Medical University Third Department of Internal Medicine Research Scientist
  • 2007 - 2014 国立がん研究センター研究所 エピゲノム解析分野
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page